Ubs Group Ag Singular Genomics Systems, Inc. Transaction History

Ubs Group Ag

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$0.4 - $0.61 $13 - $20	33 Added 0.0%	2,209,383 $1.13 Million
Q3 2023 Nov 09, 2023	SELL	$0.37 - $0.99 $914,015 - $2.45 Million	-2,470,311 Reduced 52.79%	2,209,350 $839,000
Q2 2023 Aug 11, 2023	SELL	$0.78 - $1.28 $14,124 - $23,178	-18,108 Reduced 0.39%	4,679,661 $3.88 Million
Q1 2023 May 12, 2023	SELL	$1.1 - $2.95 $2,971 - $7,967	-2,701 Reduced 0.06%	4,697,769 $5.68 Million
Q4 2022 Feb 08, 2023	BUY	$1.82 - $2.71 $45,545 - $67,817	25,025 Added 0.54%	4,700,470 $9.45 Million
Q3 2022 Nov 10, 2022	BUY	$2.5 - $4.73 $358,662 - $678,589	143,465 Added 3.17%	4,675,445 $11.7 Million
Q2 2022 Aug 10, 2022	SELL	$2.86 - $6.44 $96,496 - $217,285	-33,740 Reduced 0.74%	4,531,980 $17.3 Million
Q1 2022 May 16, 2022	BUY	$5.94 - $12.09 $26.5 Million - $53.9 Million	4,454,819 Added 4016.93%	4,565,720 $28.8 Million
Q4 2021 Feb 14, 2022	BUY	$10.45 - $16.9 $941,032 - $1.52 Million	90,051 Added 431.9%	110,901 $1.28 Million
Q3 2021 Nov 15, 2021	BUY	$10.9 - $27.63 $226,175 - $573,322	20,750 Added 20750.0%	20,850 $233,000
Q2 2021 Aug 13, 2021	BUY	$23.16 - $31.17 $2,316 - $3,117	100 New	100 $3,000

1.43M

Ticker OMIC
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 71,193,296
Market Cap $1.52B
Description
Singular Genomics Systems, Inc., a life science technology company, develops next generation sequencing and multiomics technology to build products for researchers and clinicians to advance science and medicine. The company manufactures G4 Instrument, a benchtop next generation sequencer to produce genetic sequencing results, as well as associat...

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

Stay updated on Ubs Group Ag with notifications on news.